Ignite Creation Date:
2025-12-25 @ 2:56 AM
Ignite Modification Date:
2025-12-31 @ 12:23 PM
Study NCT ID:
NCT04372433
Status:
COMPLETED
Last Update Posted:
2025-02-14
First Post:
2020-04-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
IO-202 as Monotherapy and IO-202 Plus Azacitidine ± Venetoclax in Patients in AML and CMML
Sponsor:
Immune-Onc Therapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-14
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-20
First Submit QC Date:
None
Study First Post Date:
2020-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-02-14
Last Update Post Date Type:
ACTUAL